Novel mass spectrometry‐based comprehensive lipidomic analysis of plasma from patients with inflammatory bowel disease
Authors:
- 14 April 2020
- journal article
- research article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 35 (8) , 1355-1364
Abstract
Background and Aim: Lipids play important roles in inflammation and may be involved in the pathophysiology of inflammatory bowel disease (IBD). Here, we evaluated the characteristics of the plasma lipid profile in patients with IBD.Methods: Plasma samples were collected from 20 patients with Crohn's disease (CD), 20 patients with ulcerative colitis (UC), and 10 healthy volunteers (HVs) after overnight fasting. The subjects were men between 20 and 49 years of age with no history of hyperlipidemia. A total of 698 molecular species in 22 lipid classes were analyzed by ultra‐performance liquid chromatography‐electrospray ionization‐tandem mass spectrometry.Results: Lipid classes of lysophosphatidic acid, lysophosphatidylserine (LPS), phosphatidylserine (PS), and shingosine‐1‐phosphate (S1P) were significantly increased in UC patients compared with the HV. The LPS, PS, and S1P levels were significantly increased, while those of lysophosphatidylinositol and phosphatidylcholine were significantly decreased in CD patients compared with HV. Among PS species, the levels of PSacyl (PSa) 40:3, PSa 38:3, and PSa 42:4 were significantly higher in CD patients, both active and remissive stage, than in HV. The LPS 18:0 level was significantly higher in CD and UC patients compared with HV. PSa 40:3 and PSa 38:3 levels positively correlated with the Crohn's Disease Activity Index, erythrocyte sedimentation rate, and platelet count and negatively correlated with hemoglobin, hematocrit, and albumin levels in CD patients.Conclusion: The lipid profile in IBD patients exhibits significant alterations, and PS levels are associated with clinical disease activity in CD patients.Keywords
Funding Information
- Japan Agency for Medical Research and Development (JP19gm1010004h0204)
- Japan Society for the Promotion of Science (17H04159)
This publication has 36 references indexed in Scilit:
- Evidence-based clinical practice guidelines for inflammatory bowel diseaseJournal of Gastroenterology, 2018
- Age at onset is associated with the seasonal pattern of onset and exacerbation in inflammatory bowel diseaseJournal of Gastroenterology, 2017
- Dietary ω3 fatty acid exerts anti-allergic effect through the conversion to 17,18-epoxyeicosatetraenoic acid in the gutScientific Reports, 2015
- Short-Chain Fatty Acids Activate GPR41 and GPR43 on Intestinal Epithelial Cells to Promote Inflammatory Responses in MiceGastroenterology, 2013
- Mediator lipidomics in acute inflammation and resolutionThe Journal of Biochemistry, 2012
- Immunological Function of Sphingosine 1-Phosphate in the IntestineNutrients, 2012
- Ceramide and Ceramide 1-Phosphate Are Negative Regulators of TNF-α Production Induced by LipopolysaccharideThe Journal of Immunology, 2010
- Lipid Mediators in Health and Disease: Enzymes and Receptors as Therapeutic Targets for the Regulation of Immunity and InflammationAnnual Review of Pharmacology and Toxicology, 2009
- Plasma lipids and inflammation in active inflammatory bowel diseasesAlimentary Pharmacology & Therapeutics, 2008
- Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influencesGastroenterology, 2004